Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

PROCEPT BioRobotics (PRCT) Revenue (2020 - 2026)

PROCEPT BioRobotics has reported Revenue over the past 7 years, most recently at $83.1 million for Q1 2026.

  • Quarterly Revenue rose 20.2% to $83.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $322.0 million through Mar 2026, up 29.26% year-over-year, with the annual reading at $308.1 million for FY2025, 37.22% up from the prior year.
  • Revenue was $83.1 million for Q1 2026 at PROCEPT BioRobotics, up from $76.4 million in the prior quarter.
  • Over five years, Revenue peaked at $83.3 million in Q3 2025 and troughed at $14.2 million in Q1 2022.
  • The 5-year median for Revenue is $44.5 million (2024), against an average of $48.6 million.
  • Year-over-year, Revenue soared 134.76% in 2022 and then rose 11.94% in 2025.
  • A 5-year view of Revenue shows it stood at $23.8 million in 2022, then surged by 83.29% to $43.6 million in 2023, then skyrocketed by 56.57% to $68.2 million in 2024, then rose by 11.94% to $76.4 million in 2025, then increased by 8.84% to $83.1 million in 2026.
  • Per Business Quant, the three most recent readings for PRCT's Revenue are $83.1 million (Q1 2026), $76.4 million (Q4 2025), and $83.3 million (Q3 2025).